查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
肌张力障碍治疗药物的全球市场规模、份额和行业趋势分析报告：按分销渠道、给药途径、类型、区域展望和预测，2022-2028 年
市场调查报告书
商品编码
1245707

肌张力障碍治疗药物的全球市场规模、份额和行业趋势分析报告：按分销渠道、给药途径、类型、区域展望和预测，2022-2028 年

Global Dystonia Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration, By Type (GABAergic Agents, Dopaminergic Agents, Anticonvulsants Drugs), By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 200 Pages | 订单完成后即时交付

价格

肌张力障碍疗法的全球市场规模预计到 2028 年将达到 11 亿美元，预测期内復合年增长率为 5.4%。

肌张力障碍是由基底神经节功能障碍引起的，基底神经节是负责运动协调的大脑深部区域。这些大脑区域调节运动的速度和流畅性，以避免不必要的运动。肌张力障碍患者可能表现出不自主的扭曲、重复动作或异常姿势或位置。这包括手臂、腿、躯干、面部和声带。

肌张力障碍的起源尚不清楚，但许多大脑区域和连接可能会发生改变。肌张力障碍可以是遗传性的、获得性的或特发性的（原因不明）。遗传性是遗传的疾病。获得性肌张力障碍是由脑损伤或退化（例如，脑损伤或中风后）或接触药物引起的。在特发性肌张力障碍中，原因不明，并且没有大脑的解剖学损伤或退化。

COVID-19 影响分析

COVID-19 疫情正在影响医疗保健行业的运营。由于 COVID-19，包括医疗保健各个子领域在内的多个行业已被迫暂时关闭。2020 年，由于 COVID-19 引发的经济放缓，肌张力障碍药物市场出现下滑。此外，COVID-19 影响了医疗保健等行业的供应链，进一步抑制了市场增长。然而，随着疫情的缓解，企业和供应链正在恢復正常，这有望帮助市场復苏。

市场增长因素

加强药物研发

联邦政府支持增加处方药需求的计划、影响新药供应的政策（例如对基础研究支出的监管以及必须在临床试验中证明的内容）以及影响供求双方的政策。通过研发支出（例如疫苗建议）。预计製药行业的全球研发进展将促进肌张力障碍疗法的疗效及其利用，从而促进市场增长。

神经系统疾病患病率上升

根据世界卫生组织 (WHO) 的一项新研究，神经系统疾病影响着全世界多达 10 亿人。神经系统疾病影响所有国家的个人，不论年龄、性别、教育水平或金钱。每年约有 680 万人死于神经系统疾病。神经系统疾病患者、他们的家人和医疗保健专业人员很难获得适当的护理。初级卫生保健是许多人获得医疗保健的唯一途径。儘管有高效且廉价的药物可供使用，但许多神经系统疾病患者仍未得到治疗。需要加强卫生系统，以便为患有神经系统疾病的人提供更好的护理。

市场製约因素

绝大多数人无法获得所需的医疗服务

根据世界银行和世界卫生组织的一项新研究，至少有一半的人口无法获得基本医疗保健。每年都有更多的家庭因支付医疗费用而陷入贫困。目前，有 8 亿人将至少 10% 的家庭预算用于自己、生病的孩子或其他家庭成员的健康相关费用。这些成本足以让大约 1 亿人陷入极端贫困，每天的生活费不足 1.90 美元。

按类型展望

按类型划分，肌张力障碍治疗市场分为抗惊厥药、氨基丁酸能药物、多巴胺能药物等。GABAergic 药物部分在肌张力障碍治疗市场占据主导地位，2021 年收入份额最大。这种增长归因于它在治疗肌张力障碍，尤其是颈部肌张力障碍方面的益处。此外，用于治疗肌张力障碍的有效且有效的 GABAergic 药物的发现以及医疗保健专业人员更全面的处方将在预测期内推动该细分市场的扩张。

给药途径透视

根据给药途径，肌张力障碍治疗市场分为口服和注射剂。2021 年，注射剂部分在肌张力障碍治疗市场中占据了重要的收入份额。这得益于肠外给药的技术革新和肉毒桿菌注射剂的积极研发。药物，尤其是水溶液的吸收迅速而均匀。起效比口服或皮下给药快。肌内註射绕过药物的首过代谢。

分销渠道展望

按分销渠道，肌张力障碍治疗市场分为医院药房、在线供应商、药店和零售药店。2021 年，药店和零售药房部门在肌张力障碍治疗市场的收入份额最大。这是由于其广泛的分销链，并且是向消费者提供药品的最古老和最方便的渠道。零售药剂师准备和分发药物，建议消费者正确使用药物，并告知他们潜在的药物相互作用。我们还提供非处方药和一般健康建议。

区域展望

按地区划分，对北美、欧洲、亚太地区和 LAMEA 的肌张力障碍治疗市场进行了分析。到 2021 年，北美将在肌张力障碍治疗市场中占据最高的收入份额。这是由于肌张力障碍的发病率增加以及导致人群肌张力障碍的其他神经系统疾病的患病率上升。该地区还拥有发达的医疗保健基础设施、高购买力以及肌张力障碍诊断和治疗的增加。高未满足的医疗保健需求和有利的监管环境的存在预计将推动市场扩张。

目录

第一章市场范围与研究方法

  • 市场定义
  • 目的
  • 市场范围
  • 分割
    • 按分销渠道分列的肌张力障碍疗法的全球市场
    • 肌张力障碍药物的全球市场，按给药途径
    • 肌张力障碍治疗的全球市场，按类型
    • 全球肌张力障碍治疗市场，按地区
  • 调查方法

第二章市场概况

  • 是介绍
    • 概述
      • 市场构成和情景
  • 影响市场的关键因素
    • 市场驱动力
    • 市场製约因素

3 Dystonia 治疗的全球市场，按分销渠道

  • 全球药店和零售药店市场，按地区
  • 全球医院药房市场，按地区
  • 按地区分列的全球在线提供商市场

4 全球肌张力障碍治疗市场，按给药途径

  • 按地区分列的全球口服药物市场
  • 全球可注射药物市场：按地区分类

5 全球肌张力障碍治疗市场，按类型

  • 全球 GABA 能药物市场，按地区划分
  • 全球多巴胺能药物市场，按地区划分
  • 全球抗惊厥药市场：按地区
  • 全球其他地区市场

6. 肌张力障碍疗法的全球市场，按地区划分

  • 北美
    • 北美各国肌张力障碍药物市场趋势
      • 美国
      • 加拿大
      • 墨西哥
      • 其他北美
  • 欧洲
    • 欧洲肌张力障碍药物市场：按国家分类
      • 德国
      • 英国
      • 法国
      • 俄罗斯
      • 西班牙
      • 意大利
      • 欧洲其他地区
  • 亚太地区
    • 亚太地区肌张力障碍治疗市场：国家名单
      • 中国
      • 日本
      • 印度
      • 韩国
      • 新加坡
      • 马来西亚
      • 亚太其他地区
  • 拉美亚
    • 按国家分列的 LAMEA 肌张力障碍药物市场
      • 巴西
      • 阿根廷
      • 阿联酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亚
      • 其余的 LAMEA

第七章公司简介

  • Pfizer, Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Ipsen Pharma Biotech SAS
  • Hameln Pharma Gmbh（Siegfried Group, LLP）
  • Amneal Pharmaceuticals, Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Wellona Pharma

The Global Dystonia Drugs Market size is expected to reach $1.1 billion by 2028, rising at a market growth of 5.4% CAGR during the forecast period.

Dystonia is a movement disease characterized by involuntary muscle contractions that lead to repetitive sluggish motions or aberrant postures. This muscle contraction results in aberrant muscle motions and body positions. Various types of dystonia can affect a single muscle, a group of muscles, or all of the body's muscles. It is caused by illnesses such as brain injury at or around birth, certain infections, brain trauma, and other vascular abnormalities, including stroke, arteriovenous, and others.

Patients may experience unpleasant movements or tremors as a result. There is no specific treatment for dystonia. However, its symptoms can be alleviated with various drugs. Uncontrollable muscular contractions characterize the neurological movement disorder dystonia. It is a condition that has no age, ethnic, or racial borders; it can afflict children and people of all races and ethnicities from infancy to old age.

Dystonia is caused by faulty basal ganglia functioning, a deep brain region that controls movement coordination. These brain regions regulate the speed and fluidity of movement and avoid undesired motions. Dystonic patients may exhibit involuntary twisting, repeated motions, or aberrant postures and positions. This includes the arms, legs, trunk, face, and vocal cords.

The origin of dystonia is unknown, but it may entail alterations in many brain regions or their connectivity. Dystonia may be genetic, acquired, or idiopathic in origin (no known cause). Inherited illnesses are genetically transmitted. In acquired forms, dystonia is caused by brain damage or degeneration (e.g., following a brain injury or stroke) or drug exposure. There is no known cause and no anatomical injury or degeneration of the brain in idiopathic dystonia.

COVID-19 Impact Analysis

The outbreak of COVID-19 has affected operations in the healthcare sector. Several industries, including various sub-domains of health care, have been forced to close temporarily due to COVID-19. In 2020, the market for dystonia drugs declined due to the economic slowdown triggered by COVID-19. Furthermore, COVID-19 impacted the supply chain in businesses such as healthcare, further restricting the market growth. However, with ease in the pandemic, businesses and supply chains are returning to normal, which is expected to aid the market in recovery.

Market Growth Factors

Enhancement of pharmaceutical research and development

The federal government influences private spending on research and development through programs that increase the demand for prescription drugs, through policies (like spending for basic research and regulations on what must be demonstrated in clinical trials) that affect the supply of new medicines, and through policies (like vaccine recommendations) that affect both supply and demand. The growing R&D in the pharmaceutical industry globally is expected to enhance the effectiveness of dystonia drugs and their utilization, thereby boosting the market growth.

Rise in the prevalence of neurological illnesses

According to new research from the World Health Organization (WHO), neurological illnesses impact up to one billion people globally. Neurological diseases impact individuals in all nations, regardless of age, gender, level of education, or money. Around 6.8 million people die annually due to neurological illnesses. Access to adequate care is challenging for many individuals with neurological illnesses, their families, and care providers. Primary health care is the only access to medical care for many individuals. Despite the availability of highly effective, inexpensive medications, many people with neurological disorders remain untreated. Health systems must be fortified to provide better treatment for individuals with neurological illnesses.

Market Restraining Factors

Vast amount of the population unable to receive necessary medical care.

According to new research from the World Bank and the World Health Organization, at least half of the population lacks access to crucial health care. And each year, many households are forced into poverty because they must pay for their health care. Nowadays, 800 million people spend at least 10 percent of their household budgets on health-related expenses for themselves, a sick kid, or another family member. These costs are sufficient to force about 100 million people into extreme poverty, requiring them to live on $1.90 or less per day.

Type Outlook

Based on type, the dystonia drugs market is segmented into anticonvulsants drugs, GABAergic agents, dopaminergic agents and others. The GABAergic agents segment dominated the dystonia drugs market with maximum revenue share in 2021. The growth is attributed to its benefits in treating dystonia, particularly cervical dystonia. In addition, the discovery of highly effective and potent GABAergic agent pharmaceuticals for treating dystonia, combined with its more comprehensive prescription by healthcare experts, is fueling the segment's expansion in the forecasted period.

Route of Administration Outlook

On the basis of route of administration, the dystonia drugs market is divided into oral and injectable. The injectable segment procured a substantial revenue share in the dystonia drugs market in 2021. This is because of the rise in innovations in parenteral dosing and increased research and development for botulinum injections. Absorption of the medication, especially aqueous solutions, is rapid and uniform. There is a rapid commencement of effect compared to the oral and subcutaneous methods. Injection intramuscularly bypasses the drug's first-pass metabolism.

Distribution Channel Outlook

By distribution channel, the dystonia drugs market is classified into hospital pharmacies, online providers and drug stores & retail pharmacies. The drug stores & retail pharmacies segment witnessed the largest revenue share in the dystonia drugs market in 2021. This is due to its extensive chain of distribution networks and it being the oldest and most convenient channel for providing drugs to consumers. Retail pharmacists prepare and dispense drugs, counsel consumers on the proper use of medications, and inform them of potential drug interactions. Also, retail pharmacists advise clients regarding over-the-counter medications and general health concerns.

Regional Outlook

Region-wise, the dystonia drugs market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region generated the highest revenue share in the dystonia drugs market in 2021. This is because of the growing occurrences of dystonia and the rise in the prevalence of other neurological disorders that cause dystonia in the population. In addition, the presence of a well-established healthcare infrastructure, a high purchasing power, and an increase in the diagnosis and treatment of dystonia in the region. The presence of a large number of unmet healthcare demands and a favorable regulatory environment are projected to boost the market's expansion.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Pfizer, Inc., Novartis AG, Teva Pharmaceuticals Industries Ltd., AbbVie, Inc., F. Hoffmann-La Roche Ltd., Ipsen Pharma Biotech SAS, Hameln Pharma Gmbh (Siegfried Group, LLP), Amneal Pharmaceuticals, Inc., Merz Pharma GmbH & Co. KGaA, and Wellona Pharma.

Scope of the Study

Market Segments covered in the Report:

By Distribution Channel

  • Drug Stores & Retail Pharmacies
  • Hospital Pharmacies
  • Online Providers

By Route of Administration

  • Oral
  • Injectable

By Type

  • GABAergic Agents
  • Dopaminergic Agents
  • Anticonvulsants Drugs
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Pfizer, Inc.
  • Novartis AG
  • Teva Pharmaceuticals Industries Ltd.
  • AbbVie, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Ipsen Pharma Biotech SAS
  • Hameln Pharma Gmbh (Siegfried Group, LLP)
  • Amneal Pharmaceuticals, Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Wellona Pharma

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Dystonia Drugs Market, by Distribution Channel
    • 1.4.2 Global Dystonia Drugs Market, by Route of Administration
    • 1.4.3 Global Dystonia Drugs Market, by Type
    • 1.4.4 Global Dystonia Drugs Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition & scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Dystonia Drugs Market by Distribution Channel

  • 3.1 Global Drug Stores & Retail Pharmacies Market by Region
  • 3.2 Global Hospital Pharmacies Market by Region
  • 3.3 Global Online Providers Market by Region

Chapter 4. Global Dystonia Drugs Market by Route of Administration

  • 4.1 Global Oral Market by Region
  • 4.2 Global Injectable Market by Region

Chapter 5. Global Dystonia Drugs Market by Type

  • 5.1 Global GABAergic Agents Market by Region
  • 5.2 Global Dopaminergic Agents Market by Region
  • 5.3 Global Anticonvulsants Drugs Market by Region
  • 5.4 Global Others Market by Region

Chapter 6. Global Dystonia Drugs Market by Region

  • 6.1 North America Dystonia Drugs Market
    • 6.1.1 North America Dystonia Drugs Market by Distribution Channel
      • 6.1.1.1 North America Drug Stores & Retail Pharmacies Market by Country
      • 6.1.1.2 North America Hospital Pharmacies Market by Country
      • 6.1.1.3 North America Online Providers Market by Country
    • 6.1.2 North America Dystonia Drugs Market by Route of Administration
      • 6.1.2.1 North America Oral Market by Country
      • 6.1.2.2 North America Injectable Market by Country
    • 6.1.3 North America Dystonia Drugs Market by Type
      • 6.1.3.1 North America GABAergic Agents Market by Country
      • 6.1.3.2 North America Dopaminergic Agents Market by Country
      • 6.1.3.3 North America Anticonvulsants Drugs Market by Country
      • 6.1.3.4 North America Others Market by Country
    • 6.1.4 North America Dystonia Drugs Market by Country
      • 6.1.4.1 US Dystonia Drugs Market
        • 6.1.4.1.1 US Dystonia Drugs Market by Distribution Channel
        • 6.1.4.1.2 US Dystonia Drugs Market by Route of Administration
        • 6.1.4.1.3 US Dystonia Drugs Market by Type
      • 6.1.4.2 Canada Dystonia Drugs Market
        • 6.1.4.2.1 Canada Dystonia Drugs Market by Distribution Channel
        • 6.1.4.2.2 Canada Dystonia Drugs Market by Route of Administration
        • 6.1.4.2.3 Canada Dystonia Drugs Market by Type
      • 6.1.4.3 Mexico Dystonia Drugs Market
        • 6.1.4.3.1 Mexico Dystonia Drugs Market by Distribution Channel
        • 6.1.4.3.2 Mexico Dystonia Drugs Market by Route of Administration
        • 6.1.4.3.3 Mexico Dystonia Drugs Market by Type
      • 6.1.4.4 Rest of North America Dystonia Drugs Market
        • 6.1.4.4.1 Rest of North America Dystonia Drugs Market by Distribution Channel
        • 6.1.4.4.2 Rest of North America Dystonia Drugs Market by Route of Administration
        • 6.1.4.4.3 Rest of North America Dystonia Drugs Market by Type
  • 6.2 Europe Dystonia Drugs Market
    • 6.2.1 Europe Dystonia Drugs Market by Distribution Channel
      • 6.2.1.1 Europe Drug Stores & Retail Pharmacies Market by Country
      • 6.2.1.2 Europe Hospital Pharmacies Market by Country
      • 6.2.1.3 Europe Online Providers Market by Country
    • 6.2.2 Europe Dystonia Drugs Market by Route of Administration
      • 6.2.2.1 Europe Oral Market by Country
      • 6.2.2.2 Europe Injectable Market by Country
    • 6.2.3 Europe Dystonia Drugs Market by Type
      • 6.2.3.1 Europe GABAergic Agents Market by Country
      • 6.2.3.2 Europe Dopaminergic Agents Market by Country
      • 6.2.3.3 Europe Anticonvulsants Drugs Market by Country
      • 6.2.3.4 Europe Others Market by Country
    • 6.2.4 Europe Dystonia Drugs Market by Country
      • 6.2.4.1 Germany Dystonia Drugs Market
        • 6.2.4.1.1 Germany Dystonia Drugs Market by Distribution Channel
        • 6.2.4.1.2 Germany Dystonia Drugs Market by Route of Administration
        • 6.2.4.1.3 Germany Dystonia Drugs Market by Type
      • 6.2.4.2 UK Dystonia Drugs Market
        • 6.2.4.2.1 UK Dystonia Drugs Market by Distribution Channel
        • 6.2.4.2.2 UK Dystonia Drugs Market by Route of Administration
        • 6.2.4.2.3 UK Dystonia Drugs Market by Type
      • 6.2.4.3 France Dystonia Drugs Market
        • 6.2.4.3.1 France Dystonia Drugs Market by Distribution Channel
        • 6.2.4.3.2 France Dystonia Drugs Market by Route of Administration
        • 6.2.4.3.3 France Dystonia Drugs Market by Type
      • 6.2.4.4 Russia Dystonia Drugs Market
        • 6.2.4.4.1 Russia Dystonia Drugs Market by Distribution Channel
        • 6.2.4.4.2 Russia Dystonia Drugs Market by Route of Administration
        • 6.2.4.4.3 Russia Dystonia Drugs Market by Type
      • 6.2.4.5 Spain Dystonia Drugs Market
        • 6.2.4.5.1 Spain Dystonia Drugs Market by Distribution Channel
        • 6.2.4.5.2 Spain Dystonia Drugs Market by Route of Administration
        • 6.2.4.5.3 Spain Dystonia Drugs Market by Type
      • 6.2.4.6 Italy Dystonia Drugs Market
        • 6.2.4.6.1 Italy Dystonia Drugs Market by Distribution Channel
        • 6.2.4.6.2 Italy Dystonia Drugs Market by Route of Administration
        • 6.2.4.6.3 Italy Dystonia Drugs Market by Type
      • 6.2.4.7 Rest of Europe Dystonia Drugs Market
        • 6.2.4.7.1 Rest of Europe Dystonia Drugs Market by Distribution Channel
        • 6.2.4.7.2 Rest of Europe Dystonia Drugs Market by Route of Administration
        • 6.2.4.7.3 Rest of Europe Dystonia Drugs Market by Type
  • 6.3 Asia Pacific Dystonia Drugs Market
    • 6.3.1 Asia Pacific Dystonia Drugs Market by Distribution Channel
      • 6.3.1.1 Asia Pacific Drug Stores & Retail Pharmacies Market by Country
      • 6.3.1.2 Asia Pacific Hospital Pharmacies Market by Country
      • 6.3.1.3 Asia Pacific Online Providers Market by Country
    • 6.3.2 Asia Pacific Dystonia Drugs Market by Route of Administration
      • 6.3.2.1 Asia Pacific Oral Market by Country
      • 6.3.2.2 Asia Pacific Injectable Market by Country
    • 6.3.3 Asia Pacific Dystonia Drugs Market by Type
      • 6.3.3.1 Asia Pacific GABAergic Agents Market by Country
      • 6.3.3.2 Asia Pacific Dopaminergic Agents Market by Country
      • 6.3.3.3 Asia Pacific Anticonvulsants Drugs Market by Country
      • 6.3.3.4 Asia Pacific Others Market by Country
    • 6.3.4 Asia Pacific Dystonia Drugs Market by Country
      • 6.3.4.1 China Dystonia Drugs Market
        • 6.3.4.1.1 China Dystonia Drugs Market by Distribution Channel
        • 6.3.4.1.2 China Dystonia Drugs Market by Route of Administration
        • 6.3.4.1.3 China Dystonia Drugs Market by Type
      • 6.3.4.2 Japan Dystonia Drugs Market
        • 6.3.4.2.1 Japan Dystonia Drugs Market by Distribution Channel
        • 6.3.4.2.2 Japan Dystonia Drugs Market by Route of Administration
        • 6.3.4.2.3 Japan Dystonia Drugs Market by Type
      • 6.3.4.3 India Dystonia Drugs Market
        • 6.3.4.3.1 India Dystonia Drugs Market by Distribution Channel
        • 6.3.4.3.2 India Dystonia Drugs Market by Route of Administration
        • 6.3.4.3.3 India Dystonia Drugs Market by Type
      • 6.3.4.4 South Korea Dystonia Drugs Market
        • 6.3.4.4.1 South Korea Dystonia Drugs Market by Distribution Channel
        • 6.3.4.4.2 South Korea Dystonia Drugs Market by Route of Administration
        • 6.3.4.4.3 South Korea Dystonia Drugs Market by Type
      • 6.3.4.5 Singapore Dystonia Drugs Market
        • 6.3.4.5.1 Singapore Dystonia Drugs Market by Distribution Channel
        • 6.3.4.5.2 Singapore Dystonia Drugs Market by Route of Administration
        • 6.3.4.5.3 Singapore Dystonia Drugs Market by Type
      • 6.3.4.6 Malaysia Dystonia Drugs Market
        • 6.3.4.6.1 Malaysia Dystonia Drugs Market by Distribution Channel
        • 6.3.4.6.2 Malaysia Dystonia Drugs Market by Route of Administration
        • 6.3.4.6.3 Malaysia Dystonia Drugs Market by Type
      • 6.3.4.7 Rest of Asia Pacific Dystonia Drugs Market
        • 6.3.4.7.1 Rest of Asia Pacific Dystonia Drugs Market by Distribution Channel
        • 6.3.4.7.2 Rest of Asia Pacific Dystonia Drugs Market by Route of Administration
        • 6.3.4.7.3 Rest of Asia Pacific Dystonia Drugs Market by Type
  • 6.4 LAMEA Dystonia Drugs Market
    • 6.4.1 LAMEA Dystonia Drugs Market by Distribution Channel
      • 6.4.1.1 LAMEA Drug Stores & Retail Pharmacies Market by Country
      • 6.4.1.2 LAMEA Hospital Pharmacies Market by Country
      • 6.4.1.3 LAMEA Online Providers Market by Country
    • 6.4.2 LAMEA Dystonia Drugs Market by Route of Administration
      • 6.4.2.1 LAMEA Oral Market by Country
      • 6.4.2.2 LAMEA Injectable Market by Country
    • 6.4.3 LAMEA Dystonia Drugs Market by Type
      • 6.4.3.1 LAMEA GABAergic Agents Market by Country
      • 6.4.3.2 LAMEA Dopaminergic Agents Market by Country
      • 6.4.3.3 LAMEA Anticonvulsants Drugs Market by Country
      • 6.4.3.4 LAMEA Others Market by Country
    • 6.4.4 LAMEA Dystonia Drugs Market by Country
      • 6.4.4.1 Brazil Dystonia Drugs Market
        • 6.4.4.1.1 Brazil Dystonia Drugs Market by Distribution Channel
        • 6.4.4.1.2 Brazil Dystonia Drugs Market by Route of Administration
        • 6.4.4.1.3 Brazil Dystonia Drugs Market by Type
      • 6.4.4.2 Argentina Dystonia Drugs Market
        • 6.4.4.2.1 Argentina Dystonia Drugs Market by Distribution Channel
        • 6.4.4.2.2 Argentina Dystonia Drugs Market by Route of Administration
        • 6.4.4.2.3 Argentina Dystonia Drugs Market by Type
      • 6.4.4.3 UAE Dystonia Drugs Market
        • 6.4.4.3.1 UAE Dystonia Drugs Market by Distribution Channel
        • 6.4.4.3.2 UAE Dystonia Drugs Market by Route of Administration
        • 6.4.4.3.3 UAE Dystonia Drugs Market by Type
      • 6.4.4.4 Saudi Arabia Dystonia Drugs Market
        • 6.4.4.4.1 Saudi Arabia Dystonia Drugs Market by Distribution Channel
        • 6.4.4.4.2 Saudi Arabia Dystonia Drugs Market by Route of Administration
        • 6.4.4.4.3 Saudi Arabia Dystonia Drugs Market by Type
      • 6.4.4.5 South Africa Dystonia Drugs Market
        • 6.4.4.5.1 South Africa Dystonia Drugs Market by Distribution Channel
        • 6.4.4.5.2 South Africa Dystonia Drugs Market by Route of Administration
        • 6.4.4.5.3 South Africa Dystonia Drugs Market by Type
      • 6.4.4.6 Nigeria Dystonia Drugs Market
        • 6.4.4.6.1 Nigeria Dystonia Drugs Market by Distribution Channel
        • 6.4.4.6.2 Nigeria Dystonia Drugs Market by Route of Administration
        • 6.4.4.6.3 Nigeria Dystonia Drugs Market by Type
      • 6.4.4.7 Rest of LAMEA Dystonia Drugs Market
        • 6.4.4.7.1 Rest of LAMEA Dystonia Drugs Market by Distribution Channel
        • 6.4.4.7.2 Rest of LAMEA Dystonia Drugs Market by Route of Administration
        • 6.4.4.7.3 Rest of LAMEA Dystonia Drugs Market by Type

Chapter 7. Company Profiles

  • 7.1 Pfizer, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Regional & Segmental Analysis
    • 7.1.4 Research & Development Expense
  • 7.2 Novartis AG
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental and Regional Analysis
    • 7.2.4 Research & Development Expense
  • 7.3 Teva Pharmaceutical Industries Ltd.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Regional Analysis
    • 7.3.4 Research & Development Expenses
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Product Launches and Product Expansions:
  • 7.4 AbbVie, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Regional Analysis
    • 7.4.4 Research & Development Expense
  • 7.5 F. Hoffmann-La Roche Ltd.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
  • 7.6 Ipsen Pharma Biotech SAS
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
  • 7.7 Hameln Pharma Gmbh (Siegfried Group, LLP)
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Research & Development Expenses
  • 7.8 Amneal Pharmaceuticals, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental Analysis
    • 7.8.4 Research & Development Expenses
  • 7.9 Merz Pharma GmbH & Co. KGaA
    • 7.9.1 Company Overview
    • 7.9.2 Recent strategies and developments:
      • 7.9.2.1 Approvals and Trials:
  • 7.10. Wellona Pharma
    • 7.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 2 Global Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 3 Global Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 4 Global Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 5 Global Drug Stores & Retail Pharmacies Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Drug Stores & Retail Pharmacies Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Hospital Pharmacies Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Hospital Pharmacies Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Online Providers Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Online Providers Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 12 Global Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 13 Global Oral Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Oral Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Injectable Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Injectable Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 18 Global Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 19 Global GABAergic Agents Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global GABAergic Agents Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Dopaminergic Agents Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Dopaminergic Agents Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Anticonvulsants Drugs Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Anticonvulsants Drugs Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Dystonia Drugs Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Dystonia Drugs Market by Region, 2022 - 2028, USD Million
  • TABLE 29 North America Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 30 North America Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 31 North America Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 32 North America Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 33 North America Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 37 North America Online Providers Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Online Providers Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 40 North America Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 41 North America Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Injectable Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Injectable Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 46 North America Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 47 North America GABAergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America GABAergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 49 North America Dopaminergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 50 North America Dopaminergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 51 North America Anticonvulsants Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Anticonvulsants Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Dystonia Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Dystonia Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 57 US Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 58 US Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 59 US Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 60 US Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 61 US Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 62 US Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 63 US Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 64 US Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 65 Canada Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 66 Canada Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 67 Canada Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 68 Canada Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 69 Canada Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 70 Canada Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 71 Canada Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 72 Canada Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 73 Mexico Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 74 Mexico Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 75 Mexico Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 76 Mexico Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 77 Mexico Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 78 Mexico Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 79 Mexico Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 80 Mexico Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 81 Rest of North America Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 82 Rest of North America Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 83 Rest of North America Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 84 Rest of North America Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 85 Rest of North America Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 86 Rest of North America Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 87 Rest of North America Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 88 Rest of North America Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 89 Europe Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 90 Europe Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 91 Europe Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 92 Europe Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 93 Europe Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 94 Europe Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 95 Europe Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 96 Europe Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 97 Europe Online Providers Market by Country, 2018 - 2021, USD Million
  • TABLE 98 Europe Online Providers Market by Country, 2022 - 2028, USD Million
  • TABLE 99 Europe Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 100 Europe Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 101 Europe Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 102 Europe Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 103 Europe Injectable Market by Country, 2018 - 2021, USD Million
  • TABLE 104 Europe Injectable Market by Country, 2022 - 2028, USD Million
  • TABLE 105 Europe Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 106 Europe Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 107 Europe GABAergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 108 Europe GABAergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 109 Europe Dopaminergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 110 Europe Dopaminergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 111 Europe Anticonvulsants Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 112 Europe Anticonvulsants Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 113 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 114 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 115 Europe Dystonia Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 116 Europe Dystonia Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 117 Germany Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 118 Germany Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 119 Germany Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 120 Germany Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 121 Germany Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 122 Germany Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 123 Germany Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 124 Germany Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 125 UK Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 126 UK Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 127 UK Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 128 UK Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 129 UK Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 130 UK Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 131 UK Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 132 UK Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 133 France Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 134 France Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 135 France Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 136 France Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 137 France Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 138 France Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 139 France Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 140 France Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 141 Russia Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 142 Russia Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 143 Russia Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 144 Russia Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 145 Russia Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 146 Russia Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 147 Russia Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 148 Russia Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 149 Spain Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 150 Spain Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 151 Spain Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 152 Spain Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 153 Spain Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 154 Spain Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 155 Spain Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 156 Spain Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 157 Italy Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 158 Italy Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 159 Italy Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 160 Italy Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 161 Italy Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 162 Italy Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 163 Italy Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 164 Italy Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 165 Rest of Europe Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 166 Rest of Europe Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 167 Rest of Europe Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 168 Rest of Europe Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 169 Rest of Europe Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 170 Rest of Europe Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 171 Rest of Europe Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 172 Rest of Europe Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 173 Asia Pacific Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 174 Asia Pacific Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 175 Asia Pacific Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 176 Asia Pacific Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 177 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 178 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 179 Asia Pacific Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 180 Asia Pacific Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 181 Asia Pacific Online Providers Market by Country, 2018 - 2021, USD Million
  • TABLE 182 Asia Pacific Online Providers Market by Country, 2022 - 2028, USD Million
  • TABLE 183 Asia Pacific Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 184 Asia Pacific Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 185 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 186 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 187 Asia Pacific Injectable Market by Country, 2018 - 2021, USD Million
  • TABLE 188 Asia Pacific Injectable Market by Country, 2022 - 2028, USD Million
  • TABLE 189 Asia Pacific Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 190 Asia Pacific Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 191 Asia Pacific GABAergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 192 Asia Pacific GABAergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 193 Asia Pacific Dopaminergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 194 Asia Pacific Dopaminergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 195 Asia Pacific Anticonvulsants Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 196 Asia Pacific Anticonvulsants Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 197 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 198 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 199 Asia Pacific Dystonia Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 200 Asia Pacific Dystonia Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 201 China Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 202 China Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 203 China Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 204 China Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 205 China Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 206 China Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 207 China Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 208 China Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 209 Japan Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 210 Japan Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 211 Japan Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 212 Japan Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 213 Japan Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 214 Japan Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 215 Japan Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 216 Japan Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 217 India Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 218 India Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 219 India Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 220 India Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 221 India Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 222 India Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 223 India Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 224 India Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 225 South Korea Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 226 South Korea Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 227 South Korea Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 228 South Korea Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 229 South Korea Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 230 South Korea Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 231 South Korea Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 232 South Korea Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 233 Singapore Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 234 Singapore Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 235 Singapore Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 236 Singapore Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 237 Singapore Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 238 Singapore Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 239 Singapore Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 240 Singapore Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 241 Malaysia Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 242 Malaysia Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 243 Malaysia Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 244 Malaysia Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 245 Malaysia Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 246 Malaysia Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 247 Malaysia Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 248 Malaysia Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 249 Rest of Asia Pacific Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 250 Rest of Asia Pacific Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 251 Rest of Asia Pacific Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 252 Rest of Asia Pacific Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 253 Rest of Asia Pacific Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 254 Rest of Asia Pacific Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 255 Rest of Asia Pacific Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 256 Rest of Asia Pacific Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 257 LAMEA Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 258 LAMEA Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 259 LAMEA Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 260 LAMEA Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 261 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 262 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 263 LAMEA Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
  • TABLE 264 LAMEA Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
  • TABLE 265 LAMEA Online Providers Market by Country, 2018 - 2021, USD Million
  • TABLE 266 LAMEA Online Providers Market by Country, 2022 - 2028, USD Million
  • TABLE 267 LAMEA Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 268 LAMEA Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 269 LAMEA Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 270 LAMEA Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 271 LAMEA Injectable Market by Country, 2018 - 2021, USD Million
  • TABLE 272 LAMEA Injectable Market by Country, 2022 - 2028, USD Million
  • TABLE 273 LAMEA Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 274 LAMEA Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 275 LAMEA GABAergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 276 LAMEA GABAergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 277 LAMEA Dopaminergic Agents Market by Country, 2018 - 2021, USD Million
  • TABLE 278 LAMEA Dopaminergic Agents Market by Country, 2022 - 2028, USD Million
  • TABLE 279 LAMEA Anticonvulsants Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 280 LAMEA Anticonvulsants Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 281 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 282 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 283 LAMEA Dystonia Drugs Market by Country, 2018 - 2021, USD Million
  • TABLE 284 LAMEA Dystonia Drugs Market by Country, 2022 - 2028, USD Million
  • TABLE 285 Brazil Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 286 Brazil Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 287 Brazil Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 288 Brazil Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 289 Brazil Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 290 Brazil Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 291 Brazil Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 292 Brazil Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 293 Argentina Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 294 Argentina Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 295 Argentina Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 296 Argentina Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 297 Argentina Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 298 Argentina Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 299 Argentina Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 300 Argentina Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 301 UAE Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 302 UAE Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 303 UAE Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 304 UAE Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 305 UAE Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 306 UAE Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 307 UAE Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 308 UAE Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 309 Saudi Arabia Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 310 Saudi Arabia Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 311 Saudi Arabia Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 312 Saudi Arabia Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 313 Saudi Arabia Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 314 Saudi Arabia Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 315 Saudi Arabia Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 316 Saudi Arabia Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 317 South Africa Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 318 South Africa Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 319 South Africa Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 320 South Africa Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 321 South Africa Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 322 South Africa Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 323 South Africa Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 324 South Africa Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 325 Nigeria Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 326 Nigeria Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 327 Nigeria Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 328 Nigeria Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 329 Nigeria Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 330 Nigeria Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 331 Nigeria Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 332 Nigeria Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 333 Rest of LAMEA Dystonia Drugs Market, 2018 - 2021, USD Million
  • TABLE 334 Rest of LAMEA Dystonia Drugs Market, 2022 - 2028, USD Million
  • TABLE 335 Rest of LAMEA Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 336 Rest of LAMEA Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 337 Rest of LAMEA Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
  • TABLE 338 Rest of LAMEA Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
  • TABLE 339 Rest of LAMEA Dystonia Drugs Market by Type, 2018 - 2021, USD Million
  • TABLE 340 Rest of LAMEA Dystonia Drugs Market by Type, 2022 - 2028, USD Million
  • TABLE 341 Key Information - Pfizer, Inc.
  • TABLE 342 Key Information - Novartis AG
  • TABLE 343 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 344 Key information - AbbVie, Inc.
  • TABLE 345 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 346 Key Information - Ipsen Pharma Biotech SAS
  • TABLE 347 Key Information - Hameln Pharma Gmbh
  • TABLE 348 Key Information - Amneal Pharmaceuticals, INc.
  • TABLE 349 Key information - Merz Pharma GmbH & Co. KGaA
  • TABLE 350 Key Information - Wellona Pharma

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Dystonia Drugs Market Share by Distribution Channel, 2021
  • FIG 3 Global Dystonia Drugs Market Share by Distribution Channel, 2028
  • FIG 4 Global Dystonia Drugs Market by Distribution Channel, 2018 - 2028, USD Million
  • FIG 5 Global Dystonia Drugs Market Share by Route of Administration, 2021
  • FIG 6 Global Dystonia Drugs Market Share by Route of Administration, 2028
  • FIG 7 Global Dystonia Drugs Market by Route of Administration, 2018 - 2028, USD Million
  • FIG 8 Global Dystonia Drugs Market Share by Type, 2021
  • FIG 9 Global Dystonia Drugs Market Share by Type, 2028
  • FIG 10 Global Dystonia Drugs Market by Type, 2018 - 2028, USD Million
  • FIG 11 Global Dystonia Drugs Market Share by Region, 2021
  • FIG 12 Global Dystonia Drugs Market Share by Region, 2028
  • FIG 13 Global Dystonia Drugs Market by Region, 2018 - 2028, USD Million